Tactile Systems Technology TCMD
NASDAQ TCMD
$23.23 -0.38 (-1.59%)
At close: Aug 20, 2026 · 2:35 PM UTC

Tactile Systems Technology (TCMD) Net Income towards Common Stockholders (2015 - 2026)

Tactile Systems Technology (TCMD) posted quarterly Net Income towards Common Stockholders of -$1.8 million for Q1 2026, up 40.66% year-over-year from -$1.3 million in Q1 2025, and down 116.71% quarter-over-quarter from $10.5 million in Q4 2025.

Tactile Systems Technology (TCMD) Net Income towards Common Stockholders (2015 - 2026) Analysis & Trends

Tactile Systems Technology (TCMD) has reported Net Income towards Common Stockholders for 12 consecutive years, with -$1.8 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders rose 40.66% year-over-year to -$1.8 million; the TTM figure through Mar 2026 stood at $20.2 million (up 24.6% YoY), while the FY2025 annual figure was $19.0 million, up 12.26% from the prior year.
  • Net Income towards Common Stockholders retreated to -$1.8 million in Q1 2026 per TCMD's latest filing, from $10.5 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $22.3 million in Q3 2023 and bottomed at -$15.6 million in Q1 2022.
  • Historically, Net Income towards Common Stockholders has averaged $2.6 million across 5 years, with a median of $3.2 million in 2025.
  • Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders plunged 587.03% — and 2024, when it surged 4398.0%.
  • Tactile Systems Technology's Net Income towards Common Stockholders stood at $4.6 million in 2022, then jumped by 77.49% to $8.2 million in 2023, then increased by 19.02% to $9.8 million in 2024, then rose by 8.06% to $10.5 million in 2025, then plunged by 116.71% to -$1.8 million in 2026.
  • Business Quant data shows TCMD's Net Income towards Common Stockholders at -$1.8 million in Q1 2026, $10.5 million in Q4 2025, and $8.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn 928.00 Mn
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn 1.28 Bn
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn 621.86 Mn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn 201.00 Mn
10 Tactile Systems Technology 526.55 Mn 441.77 Mn 65.35 Mn 7.79 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 7.79 Mn
Mar 31, 2026 -1.76 Mn
Dec 31, 2025 10.55 Mn
Sep 30, 2025 8.24 Mn
Jun 30, 2025 3.22 Mn
Mar 31, 2025 -2.97 Mn
Dec 31, 2024 9.76 Mn
Sep 30, 2024 5.16 Mn
Jun 30, 2024 4.30 Mn
Mar 31, 2024 -2.21 Mn
Dec 31, 2023 8.20 Mn
Sep 30, 2023 22.29 Mn
Jun 30, 2023 -100,000.00
Mar 31, 2023 -1.89 Mn
Dec 31, 2022 4.62 Mn
Sep 30, 2022 -2.28 Mn
Jun 30, 2022 -4.64 Mn
Mar 31, 2022 -15.57 Mn
Dec 31, 2021 -7.50 Mn
Sep 30, 2021 -3.36 Mn